Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, offering promising progress across many health-related and industrial purposes. With its structural similarity to By natural means derived human serum albumin, OsrHSA gives a safer, much more responsible alternate for therapeutic use